The US Food and Drug Administration (FDA) has granted humanitarian device exemption marketing approval to BSD Medical’s BSD-2000 hyperthermia system

The BSD-2000 is approved for use along with radiation therapy for the treatment of cervical cancer patients.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The hyperthermia system generates localised therapeutic heating by applying radiofrequency energy.

BSD Medical CEO Harold Wolcott said the approval provides clinicians with a new device for cervical cancer patients who are candidates for radiation therapy but ineligible for chemotherapy.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact